The SiroSkin study: A multi-centre randomised double-blind placebo-controlled trial of 1% topical sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ... (Stream 7) | Project

Director, Frazer Institute: Faculty of Health, Medicine and Behavioural Sciences

Affiliate of Dermatology Research Centre: Dermatology Research Centre; Faculty of Health, Medicine and Behavioural Sciences

Kiarash Khosrotehrani

Mayne Chair and Head of the Mayne Academy of Medicine (Secondment): Medical School; Faculty of Health, Medicine and Behavioural Sciences

Professor in Thoracic Med (Second): Prince Charles Hospital Northside Clinical Unit; Faculty of Health, Medicine and Behavioural Sciences

Dan Chambers

Associate Professor Dermatology: Frazer Institute; Faculty of Health, Medicine and Behavioural Sciences

Helmut Schaider

The SiroSkin study: A multi-centre randomised double-blind placebo-controlled trial of 1% topical sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ... (Stream 7) (2022-2027)